Furthermore, ATRA has been shown to antagonize aberrant Wnt signaling in colorectal cancer (CRC) cells by binding of the RAR/RXR heterodimer to highly conserved sequences in the N-terminus of CBP, thus mimicking the CBP/β-catenin antagonism exerted by small molecules [56]. Here, CREBBP is linked to colorectal carcinoma.